αVβ8 integrin targeting to prevent posterior capsular opacification

Area of Science:

• Ophthalmology
• Cell Biology
• Integrin Signaling

Background:

• Posterior capsular opacification (PCO) is a significant complication following cataract surgery.
• Transforming growth factor-β (TGF-β) signaling is a known driver of fibrotic PCO.
• The specific αV integrin heterodimer mediating TGF-β-induced PCO remained unidentified.

Purpose of the Study:

• To identify the functional αV integrin heterodimer involved in TGF-β-mediated PCO.
• To investigate the role of β8 integrin in the fibrotic response of lens epithelial cells (LCs) post-cataract surgery (PCS).
• To evaluate the therapeutic potential of targeting αVβ8 integrin for PCO.

Main Methods:

• Generation of β8 integrin-conditional knockout (β8ITG-cKO) mice and β5/β6 integrin-null mice.
• RNA sequencing (RNA-Seq) of LCs at 24 hours PCS.
• In vivo treatment with active TGF-β1 or an anti-αVβ8 integrin blocking antibody.

Main Results:

• β8ITG-cKO LCs exhibited attenuated fibrotic responses, unlike β5/β6 integrin-null LCs.
• RNA-Seq showed reduced upregulation of integrins, ligands, and TGF-β targets in β8ITG-cKO LCs.
• Anti-αVβ8 antibody treatment ameliorated TGF-β signaling and fibrotic responses, with significant reversal when administered post-induction.

Conclusions:

• αVβ8 integrin is a critical regulator of TGF-β activation by LCs in the context of PCO.
• Targeting αVβ8 integrin represents a potential therapeutic strategy for preventing and treating fibrotic PCO.